Why the study?
Does a nine-gene signature predict the likelihood of metastasis more accurately than traditional staging in patients with thymomas?
Does a nine-gene signature predict the likelihood of metastasis more accurately than traditional staging in patients with thymomas?
A novel nine-gene signature predicts metastasis in thymomas more accurately than traditional staging, potentially improving patient management.
Answers are grounded in this paper and cite their sources.
May refine thymoma metastasis risk stratification; leaves open prospective validation before guiding management.
A nine-gene signature was established and validated which predicts the likelihood of metastasis more accurately than traditional staging. This further underscores the biologic determinants of the clinical course of thymoma and may improve patient management.
No takes yet. Share an insight, caveat, or question.
Gökmen‐Polar et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: